Gómez Inmaculada Concepción Alarcón, Núñez F Cañadas, Rodríguez Nicolás Galdeano, Arrabal Juan José García, Manzano Ana Tobías, Moreno Ma Rosario Ortuño, Rivas Alicia María Martínez, Picón Josefa Sánchez
Servicio de Hematología, Complejo Hospitalario Torrecárdenas, Almería.
Rev Enferm. 2009 Nov;32(11):8-14.
Therapeutic use of oral anticoagulants began some fifty years ago. In the past decade, we have witnessed a large increase in the number of people who undergo oral anticoagulant treatment. A correct applied control on these patients, whether that control be carried out in a hospital setting or in a primary health care center, has been demonstrated to be effective in preventing serious complications; this fact taken into account with the improved life quality gained by avoiding displacements and inconveniences makes it obvious to conclude that decentralization benefits all concerned. There are various models available to use to manage oral anticoagulant treatment. In this analysis, the authors deal with the management carried out from a primary health care center which contacts patients after their dosis has been adjusted and validated by a hematologist at the Torrecárdenas Hospital Complex. As their hypothesis, the authors of this study plan to demonstrate the possibility of decentralizing the reviews of patients undergoing oral anticoagulant treatment, thereby avoiding trips in order to control and adjust their treatment. This is a non-random clinical study whose study group has been chosen by means of a non-probability criteria. This study lasted 12 months. The subjects were chosen from patients undergoing oral anticoagulant treatment registered in the hematology service's data base at the Torrecárdenas Hospital Complex in Almeria. Applied protocol for being included in this study was decentralization of coagulation. The study sample included 38,097 patients. This study included commentaries by the patients receiving this treatment as a fundamental element to prove its effectiveness.
口服抗凝剂的治疗应用始于大约五十年前。在过去十年中，我们目睹了接受口服抗凝剂治疗的人数大幅增加。事实证明，对这些患者进行正确的应用控制，无论这种控制是在医院环境还是在初级卫生保健中心进行，都能有效预防严重并发症；考虑到避免了不便和麻烦，生活质量得到提高，显然可以得出结论，分散管理对所有相关方都有益。有多种管理口服抗凝剂治疗的模式可供使用。在本分析中，作者探讨了由初级卫生保健中心进行的管理，该中心在患者的剂量由托雷卡登纳斯医院综合大楼的血液科医生调整和验证后与患者联系。作为他们的假设，本研究的作者计划证明对接受口服抗凝剂治疗的患者进行复查分散管理的可能性，从而避免为了控制和调整治疗而奔波。这是一项非随机临床研究，其研究组是通过非概率标准选择的。这项研究持续了12个月。研究对象选自阿尔梅里亚托雷卡登纳斯医院综合大楼血液科服务数据库中登记的接受口服抗凝剂治疗的患者。纳入本研究的应用方案是凝血的分散管理。研究样本包括38097名患者。本研究将接受这种治疗的患者的评论作为证明其有效性的基本要素。
